Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Teva invests in Gamida-Cell

March 14, 2003

OSI to market Novantrone in oncology indications

March 14, 2003

Lorus allowed U.S. patent that protects key antisense target

March 14, 2003

Kosan Biosciences receives SBIR grant to develop production method for laulimalide

March 14, 2003

Transarterial 131I-lipiodol in HCC

March 13, 2003

Ariad focuses resources on anticancer candidates

March 13, 2003

Novel series of antiangiogenic tyrosine kinase inhibitors for cancer and other disorders

March 13, 2003

Novel agents for enhancing DNA-damaging antitumor activity

March 13, 2003

Quinoline Src kinase inhibitors in AstraZeneca pipeline

March 13, 2003

Enrollment completed in phase III trial of Aptosyn/Taxotere in NSCLC

March 12, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...